PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management
touchCONGRESS for touchONCOLOGY
Listen to renowned prostate cancer expert Prof. Oliver Sartor review key data presented at the recent EMSO 2023 congress on new and emerging data that addresses key clinical questions on the use of radiopharmaceuticals in advanced prostate cancer. He also discusses with two additional leading experts, Prof. Francesco Ceci and Dr Heather Jacene, how these data may apply in clinical practice.
Overview
Data reviews with Prof. Oliver Sartor
Expert panel discussions with Prof. Francesco Ceci and Dr Heather Jacene on the themes below
Clinical themes
Refining the use…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.